PresentationOkay. Good morning, everybody. I'm Kristen Kluska, one of the biotech analyst at Cantor. Thank you so much to the Esperion Therapeutics team for being here today. We have Sheldon Koenig, the CEO; and Ben Halladay, the CFO. Thanks again for being here.Yes, our first conference together. Cool. So maybe to start, can you just provide a very high-level overview, and then we'll get into some of the specifics.Sheldon KoenigPresident, CEO & Director Yes, we'll do. First of all, again, thank you for hav ...